By Josh White
Date: Tuesday 19 Aug 2025
(Sharecast News) - Cambridge Cognition said on Tuesday that Monument Therapeutics, in which it holds a 20% stake, has partnered with the Foundation for the National Institutes of Health to trial a new treatment for schizophrenia.
By Iain Gilbert
Date: Tuesday 19 Aug 2025
(Sharecast News) - Medical diagnostics company Cambridge Nutritional Sciences said on Tuesday that it had made a marked turnaround in the year ended 31 March, with operational improvements and cost discipline helping offset a decline in headline revenues.
By Josh White
Date: Monday 11 Aug 2025
(Sharecast News) - Genedrive said in an update on Monday that its full-year income for the 12 months ended June doubled to around £1m, from £0.5m a year earlier, driven by stronger second-half sales.
Price | 10,502.03 |
Closing Price Change | -47.53 |
% Change | -0.45 % |
18-Aug-25 Close | 10,502.03 |
You are here: research